AU652882B2 - Cosmetic composition - Google Patents
Cosmetic composition Download PDFInfo
- Publication number
- AU652882B2 AU652882B2 AU32015/93A AU3201593A AU652882B2 AU 652882 B2 AU652882 B2 AU 652882B2 AU 32015/93 A AU32015/93 A AU 32015/93A AU 3201593 A AU3201593 A AU 3201593A AU 652882 B2 AU652882 B2 AU 652882B2
- Authority
- AU
- Australia
- Prior art keywords
- cosmetic composition
- composition according
- component
- carbon atoms
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
Description
1 J3247 COSMETIC COMPOSITION FIELD OF THE INVENTION This invention relates to cosmetic compositions and particularly compositions concerned with the prevention or amelioration of skin wrinkling, chapping or ageing.
BACKGROUND TO THE INVENTION AND PRIOR ART It is generally understood that ceramides present within the intercellular lipid lamellae of the stratum corneum play an important role in the production and maintenance of the water permeability barrier of the skin.
Ceramides, or substances closely related to them, have been disclosed as components of skin care compositions. In particular, Kao Corporation in GB 2 178 312 and GB 2 213 723 discloses the use of natural ceramides extracted from skin in products for topical application.
Also, Kao Corporation in EP 227 994 and EP 282 816 discloses the use of synthetic ceramides, which are similar to their natural counterparts found in skin.
It is also known that in addition to ceramides the lipid lamellae comprises sterols and fatty acids N Y Schurer, P M Elias (1991) Adv Lip Res 24 27-56 Acad Press.
2 J3247 It is believed that one of the causes of dry skin and ageing skin is a reduction in the amount of lipid contained within these intercellular lipid lamellae. It is therefore desirable to be able to successfully replace these depleted lipids by the topical route.
One suitable method for testing the ability of cosmetic compositions to effect the desired repair of the water barrier layer (ie the intercellular lipid lamellae) is to study the ability of the cosmetic composition to reduce water loss through the stratum corneum. Although previously proposed cosmetic compositions have shown a nominal level of water loss reduction, the composition according to the present invention shows a significantly improved ability for such a water loss reduction and hence provides a much more effective control of water loss and/or repair of damage to the water barrier layer in the stratum corneum.
It has been shown in Chapter 16 entitled "Aggregation of Amphiphilic Molecules into Micelles, Bilayers, Vesicles and Biological Membranes" in Intermolecular and Surface Forces, (1985) Jacob N Isrealachvili, ed Acad Press that suitable lipids for forming a bilayer are those having a polar head group and at least two hydrocarbon chains, such that there exists a clearly defined relationship between the volume occupied by the hydrocarbon chains and the optimum area occupied by the polar head group. This relationship is that: o V should be greater than 0.5 but aol c less than or equal to where V is the volume of the hydrocarbon chains lc is the critical length of the hydrocarbon chains ao is the optimum area of the polar head group 3 J3247 DEFINITION OF THE INVENTION The invention provides a cosmetic composition comprising three components A, B and C, wherein A is a molecule having at least two hydrocarbon chains and a polar head group for which V 0. 5 1.0; component aolc B is a molecule having one long hydrocarbon chain and a polar head group; and component C is capable of assisting the formation of lipid bilayers and stabilising any lipid bilayers formed in the composition; providing that the molar ratio of A:B:C is 1:1.5 to 6.0:1.1 to DISCLOSURE OF THE INVENTION The invention provides a composition suitable for topical application to the skin. The site of action of the composition is in the stratum corneum of the skin, and its mode of action is to effectively control water loss and/or a 20 to repair damage to the water barrier layer in the stratum corneum.
9 Component A *o *e Component A is a molecule having at least two hydrocarbon chains and a polar head group, providing that the volume occupied by the hydrocarbon chains and the area occupied by the polar head group fulfils the relationship V 0.5 aol where V, ic and ao are as defined above.
Preferably the hydrocarbon chains each have at least 14 carbon atoms. Furthermore it is preferred that hydrocarbon chains having less than 16 carbon atoms are fully saturated, however, hydrocarbon chains having more than 16 carbon atoms may contain 1 to 3 unsaturations if desired.
4 J3247 Suitable polar head groups may be selected from residues such as phosphates, phosphonates, sulphates, sulphonates, sulphones, hydroxyl, ethylene oxide, carboxyl and mixtures thereof. Preferably the polar head group is selected from hydroxyl groups, ethylene oxide units, carboxyl groups and mixtures thereof.
Suitable compounds that may be selected as component A are ceramides; pseudoceramides; phospholipids; glycolipids having a structure of two or more acyl or alkyl long chains suitably containing from 14 to 50 carbon atoms each, attached to a polar group; specific esters of polyethylene glycol; polyglycerol -n-x oleate (CAS 9007-48sorbitan dioleate (CAS 29116-98-1); sorbitan sesquioleate (CAS 8007-43-0); long chain alkyl ether versions of phospholipids and glycolipids; and mixtures thereof.
Ceramides *o S6 Ceramides are preferably selected from ceramides having the general structure (1) 0 11 R (CHOR 2 )m C NH CH CH 2 0R 4 (1)
R
1 A CHOR 3 where A represents CH 2
CHOR
5 CH=CH or CHOY R represents a linear or branched, saturated or 5 unsaturated aliphatic hydrocarbon group having from 1 to 49 carbon atoms, preferably from 12 to 49 carbon atoms, or a subgroup Y O (CaHb) 5 J3247 RI represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having from 8 to 28 carbon atoms, preferably from 13 to 28 carbon atoms;
R
2
R
3 and R 5 individually represent H, a phosphate residue or a sulphate residue;
R
4 represents H, a phosphate residue, a sulphate residue or a sugar residue; a is an integer of from 7 to 49, preferably from 12 to 49 b is an integer of from 10 to 98, preferably from 24 to 98 m is 0 or 1 Y represents H or a residue of a C 14 22 fatty acid having the general structure (3) 0
II
C (CHyZ,) CH 3 (3) where Z is OH or an epoxy oxygen 25 x is an integer of from 12 to y is an integer of from 20 to Sand z is 0 or an integer of from 1 to 4 Ceramides having the general structure are naturally occurring and can be isolated from a suitable plant source or from animal tissue such as pig skin or neural tissue. Ceramides can also be synthesised.
Particular preferred examples of ceramides are ceramide I and ceramide II.
6 J3247 Pseudoceramides Pseudoceramides are preferably selected from pseudoceramides (ie synthetic ceramide like structures) having the general structure 0 R 8 11 I
R
6 (CHOH)n C N CH 2
CHOR
9 (4)
I
R
7 (B)p where B represents OCH 2 or CHOH.
R
6 represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having from 1 to 49 carbon atoms preferably from 12 to 49 carbon atoms or the subgroup
R
7 represents a linear or branched, saturated or unsaturated aliphatic hydrocarbon group having from 8 to 28 carbon atoms preferably from 13 to 28 carbon atoms.
R
8 represents H, or a subgroup (CH 2 )cCOOH, where c is an integer of from 1 to 6, or a subgroup having the structure O' XI X 3 I I
(CH
2 d C CHOH S
X
2 e where X 1
X
2 and X 3 each individually represent H, a alkyl or a CI.
5 hydroxyalkyl; 7 J3247 d is 0 or an integer of from 1 to 4 e is 0 or 1 n is 0 or 1 and p is 0 or 1;
R
9 represents H, a phosphate residue, a sulphate residue or a sugar residue.
Phospholipids Phospholipids may be advantageously used because they are derivable from plant sources. An example of a suitable phospholipid material is a mixture of phospholipids derived from a particular fraction in a continuous soya bean phospholipid extraction and is sold under the trade name Ceramax by Quest International of Ashford, Kent, UK.
Glycolipids Suitable glycolipids are those having a structure of two or more acyl or alkyl long chains suitably containing from 14 to 50 carbon atoms each, attached to a polar head group. The polar head group may be selected from residues such as phosphates, phosphonates, sulphates, sulphonates, sulphones, hydroxyl, ethylene oxide, carboxyl and mixtures thereof. Preferably the polar head group is hydroxylated.
9 Suitable examples are glycosyl glycerides or diacyl or dialkyl saccharides, eg sucrose diesters with two or more 30 long chain ester groups. An example of the latter type of material is obtainable from Ryoto under the appellation Ryoto sugar esters such as Ryoto sugar ester S270, and S1570.
60 8 J3247 Esters of Polyethylene Glycol Suitable esters are: succinic acid esters having the general structure (6) O R 11 R12 0 II I I II
R
10 0 (CqH2qO)fC CH CH C (OCqH2q)g OR 13 (6) in which Rio represents an alkyl, alkenyl, mono- or dihydroxyalkyl or hydroxyalkenyl group having from 6-22 carbon atoms;
R
11 and R 12 individually represent H or an alkyl or alkenyl group having from 12 to 22 carbon atoms; providing that when R 11 is H, R 12 is an alkyl or alkenyl group and when R 12 is H, R 11 is an alkyl or alkenyl group;
R
13 represents hydrogen, an alkyl, alkenyl, mono- or dihydroxyalkyl or hydroxyalkenyl group having from 6 to 22 carbon atoms or the group 0 R1 2
R
11 0 I I II C CH CH C (CqHqO)f ORo (7) S: q is an integer of from 2 to 3 9 o f and g are average degrees of alkoxylation, namely f is S from 0 to 20 and g is from 1 to In structure the group R13 preferably represents H, while the group R10o preferably represents an alkyl group 9 having from 16 to 22 carbon atoms and most preferably from to 22 carbon atoms.
Also with reference to structure q is preferably 2 and is preferably from 1 to 9 J3247 Such succinic acid esters are synthesised using known methods of preparative chemistry, these methods are described in our co-pending patent application GB 9223578.7 filed 11 November 1992.
(ii) Polyethylene glycol r-dilaurate (CAS 9005-02-1) and polyethylene glycol r-distearate (CAS 9005-08-7).
(iii)Polyethylene glycol r-distearammonium chlorides.
These may be derived from polyethylene glycol r-tallow amine (CAS 61791) by alkylating the nitrogen with an alkyl halide having more than 8 carbon atoms.
(iv) Polyethylene glycol derivatives of long chain alkyl derivatives of malic, tartaric, maleic, malonic and glyceric acid.
where r is the number of ethylene oxide groups within the molecule and is preferably from 1 to 8, most preferably from 2 to 4.
Preferably component A comprises a mixture of the above mentioned compounds. More preferably this mixture is such that a range of chain lengths are present. Most i25 preferred are mixtures of ceramide and phospholipids, .particularly the phospholipid mixture having the trade name Ceramax, wherein the ratio of ceramide to Ceramax is from 1:1000 to 1:1, preferably from 1:50 to 1:1 and most preferably from 1:10 to 1:5 by weight.
Component B Component B is a molecule having one long hydrocarbon chain and a polar head group. A wide variety of simple cosurfactants are functional. Preferred co-surfactants are straight-chained mono carboxylic acids having 14 to carbon atoms, straight-chained fatty alcohols having 14 to 10 J3247 carbon atoms, sugar esters, alkylated sugars and mixtures thereof.
Examples of suitable sugar esters and alkylated sugars are monopalmitoyl or 6-cetyl glucose and a or P methyl 6cetyl glucoside.
Preferably the co-surfactants are chosen from straight chained mono-carboxylic acids having 14 to 24 carbon atoms, fatty alcohols having 14 to 24 carbon atoms and mixtures thereof.
The mono-carboxylic acids may be used as 50-100% sodium or potassium soap.
A particularly preferred component B is linoleic acid, since linoleic acid assists in the absorption of ultraviolet light and furthermore is a vital component of the natural skin lipids constituting the moisture barrier in the stratum corneum.
Component B may comprise a mixture of compounds, for example a fatty acid mixture of palmitic, oleic and stearic acid at 3:2:1 by weight may be employed, however particularly useful fatty acids from the point of view of availability are linoleic and stearic acid.
i. Component C Component C is a compound capable of stabilising any lipid bilayers which may be formed in the composition.
Suitable compounds may be selected from 3p-sterols; squalene; squalane; saponins or sapogenins of the plant steroid or triterpenoid type; di and tri terpenes such as phytol, retinol and amyrin; and mixtures thereof.
11 J3247 Preferably component C is a 3P-sterol having a tail on the 17 position and having no polar groups, for example cholesterol, sitosterol, stigmasterol and ergosterol.
A particularly preferred component C is the 3p-sterol ergosterol since this is well known to convert in situ into vitamin D 2 (calciferol) on reception of ultraviolet light.
It is essential that the molar ratio in which the components A, B and C are present is from 1:1.5 to 6.0:1.1 to 8.0 respectively, in order to ensure adequate control of water flux.
Preferably components A, B and C are present from 1:1.5 to 4.0:1.1 to 4.0 respectively and most preferably from 1:1.8 to 3.6:1.2 to The composition according to the invention may include a cosmetically acceptable vehicle to act as dilutant, dispersant or carrier for the components. Suitable vehicles include water, squalene, squalane, volatile silicone, liquid or solid emollients, solvents, humectants, thickeners and powders.
25 Preferably the composition includes up to 5% by welf1. t humectant, either as the vehicle or in addition to anot .r vehicle, most preferably the humectant is glycerol.
e* Examples of particular mixtures include: A Distearyl lecithin phospholipid B Octadecanol C Stigmasterol (ii) A Ceramide II (having two C 16 chains) B a long chain fatty acid of C 16 to Ci 8 C cholesterol 12 J3247 Use of the Composition The composition according to the invention is intended primarily as a product for topical application to human skin, especially as an agent for reducing the permeability of the skin to water, particularly when the skin is dry or damaged, in order to reduce moisture loss and generally to enhance the quality and flexibility of the skin. The composition can also be applied to hair and nails.
The composition may be used as a product for topical application to human skin to treat dry or ageing skin.
In use, a small quantity of the composition, for 5 example from 1 to 5 ml, is applied to exposed areas of the skin, from a suitable container or applicator and, if necessary, it is then spread over and/or rubbed into the .i skin using the hand or fingers or a suitable device.
Examples The invention is illustrated by the following examples.
Examples 1-15; Comparative Examples A-F se Compositions formulated according to the invention were tested to measure the reduction in water flux by the S. following method.
In Vitro Measurement of Water Vapour Transmission Rate The reduction in water permeability of the skin following topical application of the composition according to the invention can be determined by in vitro measurement of the water vapour transmission rate (WVTR) using a water transmission cell adapted from that described by Blank I H, J Invest Dermatol, [1952], 18, 433-440.
13 J3247 Pretreatment of Porcine Stratum Corneum Isolated porcine stratum corneum was floated on propan-2-ol contained in a glass petri dish. The dish was gently agitated for 1 hour at 40 0 C and the sample of extracted stratum corneum was then removed, floated in saline solution onto spectra mesh and air dried overnight.
Measurement of Initial WVTR Prior to Treatment 750 jl distilled water was placed in the centre well of the cell and a sample of pretreated stratum corneum (see above) was carefully laid onto a stainless steel grid over the well ensuring that the stratum corneum completely covered the 0-ring, such that a watertight seal was achieved. Care was taken to avoid wrinkles, tears and holes in the stratum corneum sample. The top of the transmission cell was then screwed into position and allowed to equilibrate at room temperature before an initial measurement was made. The cell was weighed after minutes, then placed in an incubator at 370C, 5% RH. Two further weight measurements were taken at suitable intervals over a period of 24 hours at the end of which time a test or control solution was applied and three more 25 measurements were taken during a further 21 hours. Five cells were used for each test or control treatment.
Study of the Effect of Topical Application of Test Material For each test, a solution of test material in chloroform/methanol (2:1 v/v) was prepared at 15 mg/ml concentration. 15 .l of this solution was applied to the previously selected propan-2-ol extracted skin samples as described above. The chloroform/methanol quickly evaporated. The five cells containing the skin samples were weighed after 5 minutes prior to placing in the incubator at 370C, 5% RH. As mentioned above, three weight 14 J3247 measurements were then taken at intervals over a period of 21 hours.
A control measurement was made using other selected skin samples. This was carried out in the same way using an equal quantity of chloroform/methanol containing no test material.
Calculation of the WVTR The WVTR was calculated for each sample (pre and post topical application) as follows: weight loss WVTR (mg/cm 2 /hr) Area of exposed tissue x time *54 The mean WVTR for each group of cells was then *o calculated from these values. The standard deviation was calculated from the observed changes (relative increase or decrease) in WVTR measured before and after the topical application. It was then determined whether any observed reduction in WVTR was significant compared to the control measurement by use of the Duncan's Multiple Range Test.
Results are shown in table 1, structures mentioned in this table are as follows.
0: Structure 8 0 O II II
C
1 8
H
37 O C CH CH 2
C(OC
2
H
4 )7.8E OH I (8)
C
15
H
3 1 CH2 15 -J34 J3247 Structure 9
C
22
H
45 0 C CH CH 2 C (0CAH) 7 8 EO O C1H1- CH 2 Structure 0 CH 2
CH
2
OH
11 1 CH3- CHOH C N CH 2 CHOH 15 04 0*
H
33
C
16 Structure 11 0 CH 2
CH
2 0H I I I C1H9- CHOH C N CH 2
CHOH
C
16
H
3 3 0 CH 2 (11) 0 0 0* 0 0* Structure 12 0 CH 2
CH
2
OH
11 1
C
15
H
31 C N CH 2
CHOH
C
16
H
3 3 0 -CH 2 (12) 16 -J34 J3247 Table 1.
I
Example Composition (molar ratio) Significant reduction in WVTR compared with control ceramide II :linoleic acid cholesterol Yes 2 ceramide II stearic acid :cholesterol Yes 3 ceramax sodium stearate :cholesterol Yes 4 ceramax stearic acid :cholesterol Yes (1:5.9:3.8) sucrose ester (S1570) :stearic acid cholesterol Yes (1:4.8:3.5) 6 sucrose ester (S270) :stearic acid cholesterol Yes 7 structure 8 stearic acid cholesterol Yes (1:5.8:4.2) 8 structure 9 stearic acid :cholesterol Yes 9 structure 10 stearic acid cholesterol Yes structure 11 stearic acid :cholesterol Yes S,
V
17 J3 247 Example Composition (molar ratio) ISignificant reduction in WVTR compared with control 11 ceramide. stearic acid :squalene Yes 12 ceramide palmitic, oleic and stearic acid mixture (3:2:1 by weight) Yes squalene (1:2.1:1.25) 13 distearoyl lecithin phospholipid octadecanol :stigmasterol Yes (1:5.9:3.8) 14 ceramax/ceramide (5:1 by weight) linoleic acid ergosterol Yes (1:2.16:3 .04) ceramide II stearic acid :cholesterol Yes (1:1.8:2.6) A ceramide II isostearic acid cholesterol No B structure 12 alone No C ceramide II fatty acid squalane No (1:1:1) Dceramax :cholesterol No (1:1) E lecithin :cholesterol No (2:1) F lecithin/ceramide cholesterol No .0 V a a..
Claims (16)
1. A cosmetic composition comprising three components A, B and C, wherein A is a molecule having at least two hydrocarbon chains each having at least 14 carbon atoms and a polar head group comprising a residue chosen from phosphates, phosphonates, sulphates, sulphonates, sulphones, hydroxyl,4 et oxide, carboxyl and mixtures thereof for which: V 0.5 r aol wherein 15 V is the volume of the hydrocarbon chains, lI is the critical length of the hydrocarbon chains, a 0 is the optimum area of the polar head group; component B is chosen from straight-chained mono carboxylic 20 acids having 14 to 30 carbon atoms, straight chained fatty alcohols having 14 to 30 carbon atoms, sugar esters, alkylated sugars and mixtures thereof; and component C is capable of assisting the formation of lipid bilayers and stabilising any lipid bilayers formed in the composition; 25 providing that the molar ratio of A:B:C is 1:1.5 to 6.0:1.1 to
2. A cosmetic composition according to claim 1 wherein the molar ratio of A:B:C is 1:1.5 to 4.0:1.1 to
3. A cosmetic composition according to claims 1 and 2 wherein the molar ratio of A:B:C is 1:1.8 to 3.6:1.2 to
4. A cosmetic composition according to any preceding claim wherein the polar head group of component A is chosen from hydroxyl groups, ethylene oxide units, carboxyl groups J.3201(C) AU 19 and mixtures thereof.
A cosmetic composition according to any preceding claim wherein component A is selected from ceramides; pseudoceramides; phospholipids; glycolipids having a structure of two or more acyl or alkyl long chains suitably containing from 14 to 50 carbon atoms attached to a polar head group; specific esters of polyethylene glycol; polyglycerol-n-x-oleate; sorbitan dioleate; sorbitan sesquioleate; long chain alkyl ether versions of phospholipids and glycolipids; and mixtures thereof.
6. A cosmetic composition according to any preceding claim wherein component A comprises a mixture of ceramide 15 and Ceramax in the ratio of from 1:1000 to 1:1 by weight. r e S
7. A cosmetic composition according to claim 8 wherein the ratio of ceramide to Ceramax is 1:50 to 1:1 by weight. 20
8. A cosmetic composition according to claims 8 and 9 wherein the ratio of ceramide to Ceramax is 1:10 to 1:5 by weight.
9. A cosmetic composition according to any preceding 25 claim wherein component B is chosen from straight-chained mono-carboxylic acids having 14 to 24 carbon atoms, straight chained fatty alcohols having 14 to 24 carbon atoms and mixtures thereof.
10. A cosmetic composition according to any preceding claim wherein component B is chosen from linoleic acid, stearic acid and mixtures thereof.
11. A cosmetic composition according to any preceding claim wherein component C is selected from squalene; squalane; saponins or sapogenins of the plant j sterol or triterpenoid type; di and tri terpenes; and J.3201(C) AU 20 mixtures thereof.
12. A cosmetic composition according to any preceding claim wherein component C is a 31-sterol having a tail on the 17 position and no polar groups.
13. A cosmetic composition according to any preceding claim wherein the composition additionally comprises a cosmetically acceptable vehicle. 15 o S *SS* 0B
14. A cosmetic composition according to any preceding claim wherein the composition additionally comprises up to 5% by weight humectant.
15. A cosmetic composition according to claim 14 wherein the humectant is glycerol.
16. The use of a composition according to any preceding claim in the topical treatment of dry, ageing or detergent damaged human skin or hair. DATED this 1st day of June 1994 Signed for and on behalf of UNILEVER PLC by Unilever Australia Limited R.P| ARMAN, Solicitor "I VT 21 J3247 GB ABSTRACT COSMETIC COMPOSITION A cosmetic composition effective in the reduction of water loss through the stratum corneum comprising three components A, B and C, wherein A is a molecule having at least two hydrocarbon chains and a polar head group for which: V 0.5 aol Component B is a molecule having one long hydrocarbon chain and a polar head group; and component C is capable of stabilising any lipid bilayers assisting the formulation of 00* o lipid bilayers and formed in the composition; providing that the molar ratio of A:B:C is 1:1.5 to 6.0:1.1 to *o e COo oo 0 C o S S •5
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9201476 | 1992-01-23 | ||
GB929201476A GB9201476D0 (en) | 1992-01-23 | 1992-01-23 | Cosmetic compositions |
GB929226690A GB9226690D0 (en) | 1992-12-22 | 1992-12-22 | Cosmetic composition |
GB9226690 | 1992-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3201593A AU3201593A (en) | 1993-08-12 |
AU652882B2 true AU652882B2 (en) | 1994-09-08 |
Family
ID=26300198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32015/93A Expired - Fee Related AU652882B2 (en) | 1992-01-23 | 1993-01-22 | Cosmetic composition |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0556957A1 (en) |
JP (1) | JPH0680555A (en) |
KR (1) | KR930016085A (en) |
AU (1) | AU652882B2 (en) |
BR (1) | BR9300262A (en) |
CA (1) | CA2087691A1 (en) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0644764B1 (en) * | 1992-06-19 | 2000-05-17 | The Regents of the University of California | Lipids for epidermal moisturization and repair of barrier function |
GB9220268D0 (en) * | 1992-09-25 | 1992-11-11 | Unilever Plc | Cosmetic composition |
FR2710527B1 (en) * | 1993-09-30 | 1995-12-08 | Roussel Uclaf | New cosmetic and dermatological compositions combining ceramides and linoleic acid, their preparation. |
EP0699445A3 (en) * | 1994-08-04 | 1996-04-17 | Gakko Houjin Toin Gakuen | Method for the production of microbubble-type ultrasonic contrast agent by surfactant |
GB9421185D0 (en) * | 1994-10-20 | 1994-12-07 | Unilever Plc | Personal car composition |
FR2729572A1 (en) * | 1995-01-20 | 1996-07-26 | Oreal | USE OF CERAMIDES AS A THICKENING AGENT |
FR2730410B1 (en) * | 1995-02-15 | 1997-03-21 | Oreal | COSMETIC COMPOSITION COMPRISING A COMBINATION OF CERAMIDES AND ITS USE |
FR2734721B1 (en) * | 1995-06-02 | 1997-08-14 | Clarins | DAY COSMETIC PREPARATION ACTIVATED BY LIGHT AND INTENDED TO FIGHT AGAINST SKIN AGING |
US5738856A (en) * | 1995-11-03 | 1998-04-14 | Ocular Research Of Boston, Inc. | Skin care preparation and method |
GB9602111D0 (en) * | 1996-02-02 | 1996-04-03 | Unilever Plc | Personal care composition |
GB9602608D0 (en) | 1996-02-09 | 1996-04-10 | Unilever Plc | Fabric softening composition |
FR2753200B1 (en) * | 1996-09-06 | 1998-12-04 | Fabre Pierre Dermo Cosmetique | PROCESS FOR THE EXTRACTION OF LIPIDS FROM SOY LECITHIN, LIPID EXTRACT OBTAINED AND DERMATO-COSMETIC COMPOSITIONS CONTAINING THE SAME |
GB9821778D0 (en) | 1998-10-06 | 1998-12-02 | Unilever Plc | Process and apparatus for the production of a deodorant or antiperspirant composition |
US6126954A (en) | 1999-04-05 | 2000-10-03 | Unilever Home & Personal Care Usa, Division Of Conopco | Liquid compositions comprising stable emulsion of small particle skin benefit agent |
US6440908B2 (en) | 1999-11-30 | 2002-08-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | High moisture retaining bars compositions comprising borax as water structurant |
GB0008392D0 (en) | 2000-04-05 | 2000-05-24 | Unilever Plc | Process for the production of a deodorant or antiperspirant product |
US6365138B1 (en) * | 2000-04-07 | 2002-04-02 | The Regents Of The University Of California | Compositions for metabolic protection and repair of lips |
US6660699B2 (en) | 2001-09-28 | 2003-12-09 | Unilever Home & Personal Care Usa | Toilet bar having a latent acidifier |
JP2005509610A (en) * | 2001-10-04 | 2005-04-14 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Increased skin epidermal barrier development |
BRPI0513667B1 (en) | 2004-08-16 | 2019-10-15 | Union Carbide Chemicals & Plastics Technology Llc | PERSONAL CARE COMPOSITION AND CATIONICALLY MODIFIED CELLULOSE Ether |
WO2006076065A2 (en) | 2005-01-10 | 2006-07-20 | Dow Global Technologies Inc. | Personal care compositions |
US8772212B2 (en) | 2008-08-07 | 2014-07-08 | Conopco, Inc. | Liquid personal cleansing composition |
DK2480245T3 (en) | 2009-09-25 | 2014-05-26 | Brain Biotechnology Res & Information Network Ag | New method for preparing an antimicrobial peptide |
US8017566B2 (en) | 2009-11-13 | 2011-09-13 | Conopco, Inc. | Liquid personal cleansing composition |
MX2015014565A (en) | 2013-04-16 | 2016-06-06 | Unilever Nv | Liquid soap having enhanced antibacterial activity. |
CA2935912C (en) | 2014-01-29 | 2022-05-03 | Unilever Plc | Cleansing compositions containing stable silver |
EP3099773B2 (en) | 2014-01-29 | 2020-07-22 | Unilever NV | Cleansing composition containing oligodynamic metal and efficacy enhancing agent |
US10093885B2 (en) | 2014-01-29 | 2018-10-09 | Conopco, Inc. | Aqueous composition containing oligodynamic metal |
EP3328982A1 (en) | 2015-07-29 | 2018-06-06 | Unilever NV | Low total fatty matter (tfm) cleansing bar |
CN109803532A (en) | 2016-10-07 | 2019-05-24 | 荷兰联合利华有限公司 | Personal cleansing thimerosal |
CA3047186A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Liquid personal cleansing composition |
CN110049678A (en) | 2016-12-27 | 2019-07-23 | 荷兰联合利华有限公司 | Antimicrobial compositions |
EP3621582B1 (en) | 2017-05-08 | 2021-10-13 | Unilever IP Holdings B.V. | Liquid personal cleansing composition |
WO2019086275A1 (en) | 2017-11-03 | 2019-05-09 | Unilever Plc | Skin cleansing composition and method of use |
DE202018102949U1 (en) | 2018-05-25 | 2018-06-15 | Aerox AG | Foam Oil Shower |
CA3120935A1 (en) * | 2018-11-27 | 2020-06-04 | Hollister Incorporated | Skin protectant film including skin health ingredients |
US20200375854A1 (en) | 2019-05-31 | 2020-12-03 | L'oreal | Compositions and methods for treating keratinous substrates |
WO2021026565A1 (en) | 2019-08-07 | 2021-02-11 | Mary Kay Inc. | Dissolvable vitamin c and retinol film |
WO2021163310A1 (en) | 2020-02-12 | 2021-08-19 | Curan Mehra | Water-soluble refill dose article enclosing a concentrated liquid cleanser composition and kits having same |
US11266582B2 (en) | 2020-02-12 | 2022-03-08 | Hayden Products Llc | Water-soluble refill dose article enclosing a concentrated cleanser composition and kits having same |
EP4138773A1 (en) | 2020-04-23 | 2023-03-01 | Mary Kay, Inc. | Topical cosmetic compositions |
WO2021224114A1 (en) | 2020-05-04 | 2021-11-11 | Unilever Ip Holdings B.V. | Antibacterial composition |
EP4236909A1 (en) | 2020-10-30 | 2023-09-06 | Mary Kay, Inc. | Instant effect eye cream |
JP2023547528A (en) | 2020-11-09 | 2023-11-10 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | cleansing composition |
US11268054B1 (en) | 2021-01-11 | 2022-03-08 | Hayden Products Llc | Single chamber water-soluble refill dose article enclosing a concentrated cleanser composition and kits having same |
EP4363062A1 (en) | 2021-07-01 | 2024-05-08 | Mary Kay, Inc. | Topical composition against fine lines and wrinkles |
CA3232360A1 (en) | 2021-09-28 | 2023-04-06 | Rafael Astolfi | Cleansing composition |
WO2024056586A2 (en) | 2022-09-16 | 2024-03-21 | Unilever Ip Holdings B.V. | Self-foaming cleansing composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57209207A (en) * | 1981-06-17 | 1982-12-22 | Kanebo Ltd | Creamy or milky skin cosmetic |
FR2521565B1 (en) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | PULVERULENT MIXTURE OF LIPID COMPONENTS AND HYDROPHOBIC CONSTITUENTS, METHOD FOR PREPARING SAME, HYDRATED LIPID LAMELLAR PHASES AND MANUFACTURING METHOD, PHARMACEUTICAL OR COSMETIC COMPOSITIONS COMPRISING HYDRATED LAMID PHASES |
IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
JPS63192703A (en) * | 1987-02-04 | 1988-08-10 | Kao Corp | External agent for skin |
EP0282816B1 (en) * | 1987-03-06 | 1993-09-15 | Kao Corporation | External skin care preparation |
WO1990001323A1 (en) * | 1988-08-12 | 1990-02-22 | Bernstein Joel E | Method and composition for treating and preventing dry skin disorders |
JPH0347108A (en) * | 1989-04-05 | 1991-02-28 | Kao Corp | Double-emulsified cosmetic composition |
JPH0374312A (en) * | 1989-08-10 | 1991-03-28 | Kao Corp | Cosmetic |
JPH0818948B2 (en) * | 1990-08-31 | 1996-02-28 | 花王株式会社 | Aqueous cosmetic and its manufacturing method |
-
1993
- 1993-01-20 CA CA002087691A patent/CA2087691A1/en not_active Abandoned
- 1993-01-21 JP JP5008312A patent/JPH0680555A/en active Pending
- 1993-01-21 EP EP93300449A patent/EP0556957A1/en not_active Withdrawn
- 1993-01-21 KR KR1019930000776A patent/KR930016085A/en not_active Application Discontinuation
- 1993-01-22 AU AU32015/93A patent/AU652882B2/en not_active Expired - Fee Related
- 1993-01-22 BR BR9300262A patent/BR9300262A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9300262A (en) | 1993-09-28 |
JPH0680555A (en) | 1994-03-22 |
EP0556957A1 (en) | 1993-08-25 |
KR930016085A (en) | 1993-08-26 |
CA2087691A1 (en) | 1993-07-24 |
AU3201593A (en) | 1993-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU652882B2 (en) | Cosmetic composition | |
Imokawa et al. | Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin | |
US5688752A (en) | Aqueous personal care cleanser comprising specific lipid composition | |
AU639373B2 (en) | Cosmetic composition | |
Bouwstra et al. | The role of ceramides 1 and 2 in the stratum corneum lipid organisation | |
ES2013792A6 (en) | External agent for skin | |
Yardley | Epidermal lipids | |
US20070148771A1 (en) | Reconstructed epidermis/skin equivalent comprising a ceramide 7 and/or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds | |
EP0495624A1 (en) | Cosmetic composition | |
JP5657191B2 (en) | Vesicle and topical skin preparation containing the same | |
EP0846698B1 (en) | Dermatologic external preparation | |
KR101988673B1 (en) | Improved moisturiser blend | |
EP0587288A1 (en) | Cosmetic composition containing a lipid and a hydroxy or ketacarboxylic acid | |
KR100545836B1 (en) | Cosmetic composition for skin irritation relief containing nanoliposomes of intracellular lipid components | |
Wertz et al. | Covalent attachment of ω-hydroxyacid derivatives to epidermal macromolecules: a preliminary characterization | |
Squier et al. | Thin-layer chromatographic analyses of lipids in different layers of porcine epidermis and oral epithelium | |
EP0699181B1 (en) | Linoleoylamide based ceramide derivative and its use in cosmetic preparations for the treatment of dry skin | |
Brooks et al. | Skin lipids | |
Reynods et al. | The fatty acid composition of skin and plasma lipids in Refsum's disease | |
US5489426A (en) | Cosmetic composition based on an aqueous dispersion of small lipid spheres | |
JPH0160443B2 (en) | ||
CA2386732C (en) | Compositions comprising fluid petrolatum and methods for the use thereof | |
JP4101558B2 (en) | Transparent cosmetics | |
JP2000143598A (en) | Ceramide derivative and skin cosmetic containing the same | |
JP3751261B2 (en) | Cosmetics |